Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS 0.00%·Rev n/aQ1 21EPS +13.33%·Rev n/aQ4 20EPS -4.55%·Rev n/aQ3 20EPS -16.67%·Rev n/a⚠ consensus missing

Arbutus Biopharma Corp ABUS

Pam Murphy — Investor Relations or Corporate Communications

Bill Collier — President and Chief Executive Officer

Dave Hastings — Chief Financial Officer

+10.1%1d on move date+9.5% vs SPY3d+12.0%5d+15.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABUS calls or request research access.

More ABUS calls Browse calls Request research access